Cannell & Co. - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cannell & Co. ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$293,000
+29.6%
281,983
-7.0%
0.01%
+10.0%
Q4 2018$226,000
-64.9%
303,0710.0%0.01%
-56.5%
Q3 2018$643,000
-8.1%
303,0710.0%0.02%
-11.5%
Q2 2018$700,000
-27.6%
303,071
-0.3%
0.03%
-27.8%
Q1 2018$967,000
-22.4%
303,9710.0%0.04%
-16.3%
Q4 2017$1,246,000
-9.3%
303,9710.0%0.04%
-10.4%
Q3 2017$1,374,000
+1.2%
303,971
-25.4%
0.05%
+2.1%
Q2 2017$1,358,000
-55.5%
407,741
+23.1%
0.05%
-56.5%
Q1 2017$3,051,000
+56.9%
331,296
+31.3%
0.11%
+54.3%
Q4 2016$1,945,000
-41.2%
252,228
-12.9%
0.07%
-41.7%
Q3 2016$3,309,000
-7.2%
289,5280.0%0.12%
-7.7%
Q2 2016$3,564,000
+67.6%
289,528
+37.6%
0.13%
+71.1%
Q1 2016$2,127,000
-55.1%
210,4030.0%0.08%
-50.6%
Q4 2015$4,742,000
+35.8%
210,4030.0%0.15%
+36.3%
Q3 2015$3,491,000
-15.2%
210,403
+15.0%
0.11%
-3.4%
Q2 2015$4,118,000
+242.3%
183,003
+292.3%
0.12%
+234.3%
Q1 2015$1,203,00046,6540.04%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
BVF INC/IL 4,108,815$4,273,0000.48%
Birchview Capital, LP 372,557$387,0000.24%
Perceptive Advisors 1,719,111$1,787,0000.05%
Fondren Management LP 25,136$26,0000.02%
Cannell & Co. 281,983$293,0000.01%
APPLETON PARTNERS INC/MA 66,206$69,0000.01%
Quinn Opportunity Partners LLC 66,162$69,0000.01%
NJ State Employees Deferred Compensation Plan 38,000$40,0000.01%
Candriam S.C.A. 380,000$395,0000.01%
PRIMECAP MANAGEMENT CO/CA/ 5,451,400$5,669,0000.00%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders